Alprostadil (Caverject/MUSE) Cost in Oklahoma 2026

What Is Alprostadil and Why Does Cost Vary So Much?

Alprostadil is synthetic prostaglandin E1 (PGE1). It relaxes smooth muscle in the corpus cavernosum, increasing arterial inflow and producing an erection in men with erectile dysfunction (ED) who do not respond adequately to oral PDE5 inhibitors. The FDA approved intracavernosal Caverject in 1995 and the intraurethral MUSE suppository in 1997 [1]. Because alprostadil is off-patent, generic injectable forms exist, yet brand prices remain high in the United States. In Oklahoma, the spread between a retail brand purchase and a 503A compounded vial can exceed $500 per month for the same active molecule.

Cost variation comes from three distinct supply channels: brand retail (Caverject, MUSE, Edex), FDA-approved generics, and compounded preparations from state-licensed 503A pharmacies. Each channel carries different payer rules, pharmacy markups, and regulatory requirements. Knowing which channel applies to your situation is the single fastest way to reduce spending [2].

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that ED affects roughly 30 million men in the United States, with prevalence rising steeply after age 40 [3]. Access to cost-effective treatment matters at that scale.

Brand-Name Alprostadil Prices in Oklahoma in 2026

Brand Caverject and MUSE carry a manufacturer list price of approximately $600 per month at Oklahoma retail pharmacies in 2026. The exact amount a patient pays depends on insurance, pharmacy choice, and any applicable savings card.

Caverject Impulse (Pfizer) is sold as a dual-chamber syringe system in 10 mcg and 20 mcg strengths. A six-injection kit typically retails between $380 and $480 at major Oklahoma chains such as CVS and Walgreens, making a monthly supply (assuming approximately six to eight encounters per month) exceed $600 before any discounts. Edex (alprostadil alfadex, Schwarz Pharma) follows a similar pricing band [4].

MUSE (medicated urethral system for erection) urethral suppositories are sold in packs of six in doses from 125 mcg to 1 to 000 mcg. Oklahoma retail cash prices for a six-pack range from roughly $300 to $450 depending on dose and pharmacy, meaning monthly costs again approach or exceed $600 for regular use [5].

Generic injectable alprostadil is available from several manufacturers. GoodRx and similar platforms list Oklahoma cash prices for generic alprostadil 20 mcg/mL vials (multi-dose) in the $180 to $280 range per vial, which may cover multiple doses depending on the individualized dose a clinician selects [6]. A patient titrated to 10 mcg per injection could stretch a 20 mcg/mL, 5 mL vial across several encounters, lowering effective per-use cost considerably.

The AUA (American Urological Association) 2018 guideline on erectile dysfunction (updated 2024) states that intracavernosal alprostadil produces erections sufficient for intercourse in approximately 70 to 80 percent of men with organic ED [7]. That efficacy level makes price optimization worth the effort for a drug that works when first-line oral therapy has failed.

Oklahoma Medicaid Coverage for Alprostadil

Oklahoma Medicaid does not cover alprostadil for erectile dysfunction as of 2026. This exclusion aligns with most state Medicaid programs nationally, which treat ED pharmacotherapy as a non-covered lifestyle or elective benefit.

Oklahoma's SoonerCare (the state's Medicaid program) publishes its preferred drug list (PDL) through the Oklahoma Health Care Authority (OHCA). PDE5 inhibitors such as sildenafil and tadalafil are also excluded from SoonerCare for ED in most member categories [8]. The practical outcome: nearly all SoonerCare members pay full cash price or must find alternative coverage if they are prescribed alprostadil.

A narrow exception may apply when alprostadil is prescribed for a non-ED indication. Alprostadil has FDA-approved uses in newborns with congenital heart defects (intravenous prostaglandin E1 to maintain ductal patency) [9]. Adult urological use for ED, however, sits outside SoonerCare's covered benefit for the overwhelming majority of adult members.

Patients who believe a prior authorization or medical necessity appeal could succeed should request documentation from their prescribing physician that the condition is refractory to lower-cost treatments. The OHCA exception process is outlined in OAC 317:30-5-77, though historically approvals for ED drugs under this pathway are uncommon.

Private Insurance Coverage in Oklahoma

Private insurance coverage for alprostadil in Oklahoma varies by plan, employer, and formulary tier. No blanket statewide rule requires coverage.

ACA marketplace plans sold on Oklahoma's federally facilitated exchange are not required to cover ED drugs as an essential health benefit. Many employer-sponsored plans follow suit and exclude alprostadil or place it on a specialty tier with high cost-sharing [10]. Blue Cross Blue Shield of Oklahoma, Aetna, and Cigna each publish formulary documents annually; members should search for "alprostadil" or "Caverject" in the plan's drug lookup tool to see tier placement and applicable copay or coinsurance.

Medicare Part D plans are prohibited by statute from covering drugs used primarily for ED (Social Security Act Section 1860D-2(e)(2)(A)). This prohibition covers Caverject, MUSE, and generic alprostadil when the indication is erectile dysfunction [11]. Medicare Advantage drug plans follow the same federal exclusion.

Veterans Affairs (VA) coverage: Oklahoma has a substantial veteran population served by the Jack C. Montgomery VA Medical Center in Muskogee and the VA outpatient clinic network. The VA National Formulary includes alprostadil under certain clinical criteria. Veterans with service-connected genitourinary conditions may qualify for VA-covered alprostadil; the prescribing clinician submits a non-formulary request if the specific product is not on the local formulary [12].

Compounded Alprostadil in Oklahoma: Legality and Cost

Compounded alprostadil is legal in Oklahoma when prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. Cost is the central advantage.

A 503A compounding pharmacy in Oklahoma operates under both federal USP 795/797 sterile compounding standards and state oversight from the Oklahoma State Board of Pharmacy. Intracavernosal alprostadil injections prepared under 503A can be dispensed to an individual patient with a valid prescription from a licensed prescriber [13]. The compounded preparation is not FDA-approved, but the active pharmaceutical ingredient (alprostadil) is the same molecule.

Cost at licensed Oklahoma 503A compounding pharmacies ranges widely based on concentration, volume, and the pharmacy's overhead structure. Some specialty compounding pharmacies that partner with telehealth platforms price compounded alprostadil vials in the range of $60 to $150 per month, compared to $600 for a brand product at retail. That gap is not trivial: it can represent a $450 to $540 monthly saving for patients paying out-of-pocket.

Compounded formulations sometimes combine alprostadil with papaverine and phentolamine in a preparation commonly called Trimix. Trimix is not FDA-approved as a fixed combination, but its compounded use is well-documented in the urological literature and supported by the AUA guideline [7]. Some Oklahoma compounding pharmacies also prepare Bimix (alprostadil plus papaverine). These combinations may allow lower alprostadil doses, which can reduce side effects such as penile pain [14].

503B outsourcing facilities (large-scale compounders that may sell to clinics without patient-specific prescriptions) operate under stricter FDA oversight. Patients receiving alprostadil through a telehealth-affiliated clinic may receive product from a 503B facility. Both pathways are legal; the distinction matters for understanding quality assurance standards [15].

Oklahoma does not impose additional state restrictions on compounded alprostadil beyond federal 503A requirements and the Board of Pharmacy's sterile compounding regulations. A patient in Tulsa, Oklahoma City, Lawton, or any rural county can receive a compounded vial shipped from an in-state or out-of-state licensed compounding pharmacy with a valid Oklahoma prescription.

Clinical Evidence Supporting Alprostadil Use

Alprostadil's efficacy is supported by decades of controlled trial data, not anecdote.

Linet and Ogrinc (NEJM, 1996, N=296) showed that intracavernosal alprostadil produced erections sufficient for intercourse in 94 percent of injection attempts in men with chronic ED, compared with 9 percent for placebo (P<0.001) [16]. This remains one of the most cited key trials for intracavernosal therapy.

The MUSE key trial (Padma-Nathan et al., NEJM 1997, N=1,511) found that 64.9 percent of men using intraurethral alprostadil suppositories at home had at least one successful sexual encounter over three months versus 18.6 percent for placebo [17]. Dose-response was clear: the 1 to 000 mcg suppository produced the highest response rate.

A 2010 Cochrane systematic review of intracavernosal vasoactive agents (N=36 trials) confirmed alprostadil monotherapy produces superior erectile response compared with papaverine alone, with a rate of prolonged erection (priapism risk) below 1 percent across pooled studies [18]. This safety profile informs prescriber confidence in outpatient and telehealth settings.

The International Society of Sexual Medicine (ISSM) guideline on penile rehabilitation after radical prostatectomy cites intracavernosal alprostadil as a first-line option for post-surgical ED recovery, with early use associated with preservation of erectile tissue oxygenation [19]. For Oklahoma patients who have undergone prostatectomy at OU Health or Saint Francis Hospital in Tulsa, this is a clinically meaningful consideration beyond simple cost framing.

Telehealth Prescribing of Alprostadil in Oklahoma

Oklahoma law permits telehealth prescribing of alprostadil. A licensed Oklahoma physician or advanced practice provider (APP) can evaluate a patient via synchronous audio-video and issue a valid prescription without an in-person visit, provided the clinical evaluation meets the standard of care [20].

Oklahoma's telemedicine statute (63 O.S. Section 1-102.1) does not list alprostadil as a controlled substance requiring in-person evaluation. Because alprostadil is not a scheduled drug under the Controlled Substances Act, the Ryan Haight Act's in-person requirement for controlled substance prescriptions does not apply [21]. A patient can complete an online intake, upload relevant lab work (testosterone, lipid panel, HbA1c if diabetic), attend a video consult, and receive both a diagnosis and a prescription in a single clinical encounter.

Several telehealth platforms serving Oklahoma patients offer alprostadil as part of an ED treatment protocol. The prescriber typically starts at a low test dose (2.5 mcg intracavernosal) with written dose-titration instructions, since in-office titration is the traditional standard but not always feasible in rural Oklahoma counties where the nearest urologist may be 90 miles away.

Patients new to intracavernosal injection should receive training materials on injection technique, priapism management (erections lasting more than four hours require emergency evaluation), and proper sharps disposal. Oklahoma DEQ guidelines on sharps disposal apply to home injection users [22].

How Pfizer and Generic Manufacturer Savings Programs Work in Oklahoma

Pfizer offers a Caverject savings card for commercially insured patients that can reduce copays to as low as $0 for eligible fills, subject to program terms and annual caps. Oklahoma residents with qualifying private insurance (not Medicare, Medicaid, or any government-funded plan) can enroll at the Pfizer patient savings portal [23].

The savings card does not apply to SoonerCare members, Medicare Part D enrollees, or uninsured patients paying full cash price. For cash-pay patients in Oklahoma, the GoodRx coupon consistently brings generic alprostadil prices at Walmart, CVS, and independent pharmacies below retail list. Prices fluctuate; checking GoodRx or NeedyMeds at the point of prescribing gives the most current Oklahoma-specific price [6].

NeedyMeds maintains a database of patient assistance programs (PAPs) for low-income, uninsured patients. Pfizer's PAP (Pfizer RxPathways) may supply Caverject at no cost to qualifying Oklahoma patients who meet income thresholds, typically at or below 400 percent of the federal poverty level [24]. The application requires a prescriber signature and proof of income.

The table below summarizes the four main cost pathways an Oklahoma patient faces in 2026:

| Pathway | Estimated Monthly Cost (Oklahoma, 2026) | Insurance Accepted | |---|---|---| | Brand Caverject/MUSE retail | $380 to $600+ | Commercial (if covered); not Medicaid/Medicare | | FDA-approved generic injectable | $180 to $280 per vial | Commercial; check formulary | | Compounded alprostadil (503A) | $60 to $150 | Rarely; typically cash-pay | | Pfizer PAP / savings card | $0 to low copay | Commercial only; income criteria for PAP |

Cheapest Practical Path to Alprostadil in Oklahoma

For most Oklahoma men paying out of pocket, compounded alprostadil through a telehealth-connected 503A compounding pharmacy is the lowest-cost legal route. Here is the sequence that works clinically.

Step one: obtain a telehealth evaluation with an Oklahoma-licensed prescriber. Step two: have the prescriber send the prescription to a licensed 503A compounding pharmacy that ships to Oklahoma addresses. Step three: perform an in-home test injection at the starting dose (2.5 mcg) and titrate per written instructions over one to two weeks. Step four: confirm the effective dose and establish a monthly supply.

Men with commercial insurance should run their alprostadil prescription through GoodRx and through their insurance formulary simultaneously, then use whichever produces the lower out-of-pocket amount. Generic alprostadil at a GoodRx price may undercut the insurance copay at specialty tier, particularly for plans that assign a 30 to 50 percent coinsurance on specialty drugs.

Veterans in Oklahoma should contact their VA primary care team before purchasing commercially. VA-covered alprostadil, when authorized, costs the veteran a standard medication copay (roughly $11 to $44 per 30-day supply for most VA copay tiers), which is lower than any commercial option [12].

Side Effects and Safety Considerations Relevant to Cost Decisions

Understanding alprostadil side effects informs cost decisions because inadequate dose selection leads to treatment abandonment or emergency visits, both of which have real financial consequences.

Penile pain is the most common adverse effect of intracavernosal alprostadil, reported in approximately 37 percent of patients in the Linet NEJM trial [16]. Pain tends to decrease with repeated use and with dose optimization. Starting at 2.5 mcg and titrating slowly reduces pain incidence [7].

Priapism (erection lasting more than four hours) occurs in less than 1 percent of uses with alprostadil monotherapy [18]. Oklahoma patients should know that emergency treatment at an ER, if required, involves corporal aspiration and possible sympathomimetic injection, with costs that can far exceed several months of medication. Dose discipline is the practical prevention strategy.

Fibrosis at the injection site (Peyronie's-like plaques) may develop with long-term use in 2 to 3 percent of patients [7]. Rotating injection sites and maintaining the lowest effective dose mitigates risk. A urologist visit if fibrosis is suspected adds a cost variable patients should anticipate.

Systemic hypotension is rare with intracavernosal alprostadil at doses below 40 mcg but occurs more frequently with MUSE due to systemic absorption through the urethral mucosa. The FDA labeling for MUSE recommends an initial in-office dose with blood pressure monitoring [1].

Finding an Oklahoma Provider Who Prescribes Alprostadil

Alprostadil is prescribed by urologists, men's health specialists, endocrinologists, and primary care physicians in Oklahoma. The Oklahoma Urology Center in Oklahoma City and Urology Associates of Tulsa both list ED therapy among their services. Academic centers such as OU Health (Oklahoma City) and OSU Medical Center (Tulsa) have men's health clinics where intracavernosal therapy training is available.

For rural Oklahoma counties, telehealth is the realistic access point. The Oklahoma Office of Rural Health supports telehealth infrastructure across frontier counties, and a growing number of national men's health telehealth platforms hold Oklahoma provider licenses [20].

The AUA recommends that any patient starting intracavernosal injection therapy receive instruction on self-injection technique from a clinician or trained nurse, even if follow-up care is conducted remotely [7]. Video-based instruction, supported by written materials, satisfies this requirement for patients who cannot travel.